(VRLA) Verallia - Ratings and Ratios
Glass Bottles, Glass Jars
Description: VRLA Verallia
Verallia Société Anonyme is a leading global manufacturer of glass packaging products, catering to the beverage and food industries. The companys product portfolio includes a wide range of bottles and jars for various applications, as well as value-added services. With a rich history dating back to 1827, Verallia is headquartered in Courbevoie, France, and operates globally.
From a financial perspective, Verallias market capitalization stands at approximately €3.3 billion, indicating a significant presence in the industry. The companys Return on Equity (RoE) of 77.21% suggests a high level of profitability, potentially driven by efficient operations and a strong market position. To further evaluate Verallias performance, key metrics such as Revenue Growth, EBITDA Margin, and Debt-to-Equity Ratio could be analyzed. For instance, a high EBITDA Margin would indicate the companys ability to maintain profitability, while a low Debt-to-Equity Ratio would suggest a healthy balance sheet.
To assess Verallias stock performance, we can examine its Price-to-Earnings (P/E) ratio, which currently stands at 14.15. The Forward P/E ratio of 6.53 suggests that analysts expect earnings to grow significantly in the future. Additionally, the stocks 52-week high and low prices indicate a relatively stable trading range. To gain further insights, we could analyze the stocks trading volume, institutional ownership, and short interest. For example, a high trading volume would indicate liquidity, while a significant institutional ownership would suggest confidence in the companys prospects.
From a technical analysis perspective, Verallias stock price is currently trading near its 52-week high, with a relatively stable short-term trend indicated by the SMA20 and SMA50. The stocks ATR suggests a low level of volatility. To further evaluate the stocks technicals, we could examine indicators such as the Relative Strength Index (RSI), Bollinger Bands, or the Moving Average Convergence Divergence (MACD). For instance, a bullish RSI or a golden cross on the MACD would indicate a potential buying opportunity.
VRLA Stock Overview
Market Cap in USD | 3,263m |
Sub-Industry | Paper & Plastic Packaging Products & Materials |
IPO / Inception |
VRLA Stock Ratings
Growth Rating | 36.5% |
Fundamental | 74.9% |
Dividend Rating | 84.8% |
Return 12m vs S&P 500 | -18.1% |
Analyst Rating | - |
VRLA Dividends
Dividend Yield 12m | 6.78% |
Yield on Cost 5y | 8.96% |
Annual Growth 5y | 20.39% |
Payout Consistency | 100.0% |
Payout Ratio | 112.6% |
VRLA Growth Ratios
Growth Correlation 3m | -48.8% |
Growth Correlation 12m | 63.8% |
Growth Correlation 5y | 47.1% |
CAGR 5y | 6.18% |
CAGR/Max DD 3y | 0.13 |
CAGR/Mean DD 3y | 0.26 |
Sharpe Ratio 12m | -0.14 |
Alpha | -24.22 |
Beta | 0.838 |
Volatility | 23.24% |
Current Volume | 59k |
Average Volume 20d | 67k |
Stop Loss | 23 (-3.1%) |
Signal | -0.11 |
Piotroski VR‑10 (Strict, 0-10) 4.5
Net Income (462.5m TTM) > 0 and > 6% of Revenue (6% = 416.4m TTM) |
FCFTA 0.08 (>2.0%) and ΔFCFTA -4.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 0.01% (prev -0.06%; Δ 0.08pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.25 (>3.0%) and CFO 1.13b > Net Income 462.5m (YES >=105%, WARN >=100%) |
Net Debt (1.78b) to EBITDA (1.20b) ratio: 1.48 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (117.8m) change vs 12m ago 0.48% (target <= -2.0% for YES) |
Gross Margin 19.45% (prev 24.98%; Δ -5.54pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 154.7% (prev 123.0%; Δ 31.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 4.37 (EBITDA TTM 1.20b / Interest Expense TTM 157.9m) >= 6 (WARN >= 3) |
Altman Z'' 1.92
(A) 0.00 = (Total Current Assets 1.43b - Total Current Liabilities 1.42b) / Total Assets 4.51b |
(B) 0.17 = Retained Earnings (Balance) 764.1m / Total Assets 4.51b |
(C) 0.15 = EBIT TTM 689.7m / Avg Total Assets 4.49b |
(D) 0.32 = Book Value of Equity 1.17b / Total Liabilities 3.66b |
Total Rating: 1.92 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.85
1. Piotroski 4.50pt = -0.50 |
2. FCF Yield 7.66% = 3.83 |
3. FCF Margin 5.42% = 1.35 |
4. Debt/Equity 2.58 = -0.13 |
5. Debt/Ebitda 1.83 = 0.34 |
6. ROIC - WACC 11.52% = 12.50 |
7. RoE 51.14% = 2.50 |
8. Rev. Trend 69.93% = 3.50 |
9. Rev. CAGR 13.90% = 1.74 |
10. EPS Trend -11.19% = -0.28 |
11. EPS CAGR 0.0% = 0.0 |
What is the price of VRLA shares?
Over the past week, the price has changed by -1.82%, over one month by -15.82%, over three months by -15.52% and over the past year by -2.49%.
Is Verallia a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VRLA is around 22.36 EUR . This means that VRLA is currently overvalued and has a potential downside of -5.81%.
Is VRLA a buy, sell or hold?
What are the forecasts/targets for the VRLA price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 31.1 | 31.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 24.4 | 2.6% |
VRLA Fundamental Data Overview
Market Cap EUR = 2.79b (2.79b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 74.6m EUR (last quarter)
P/E Trailing = 15.6689
P/E Forward = 6.5274
P/S = 0.8166
P/B = 3.3121
Beta = 0.843
Revenue TTM = 6.94b EUR
EBIT TTM = 689.7m EUR
EBITDA TTM = 1.20b EUR
Long Term Debt = 1.88b EUR (from longTermDebt, last quarter)
Short Term Debt = 321.2m EUR (from shortTermDebt, last quarter)
Debt = 2.20b EUR (Calculated: Short Term 321.2m + Long Term 1.88b)
Net Debt = 1.78b EUR (from netDebt column, last fiscal year)
Enterprise Value = 4.91b EUR (2.79b + Debt 2.20b - CCE 74.6m)
Interest Coverage Ratio = 4.37 (Ebit TTM 689.7m / Interest Expense TTM 157.9m)
FCF Yield = 7.66% (FCF TTM 375.9m / Enterprise Value 4.91b)
FCF Margin = 5.42% (FCF TTM 375.9m / Revenue TTM 6.94b)
Net Margin = 6.66% (Net Income TTM 462.5m / Revenue TTM 6.94b)
Gross Margin = 19.45% ((Revenue TTM 6.94b - Cost of Revenue TTM 5.59b) / Revenue TTM)
Tobins Q-Ratio = 4.19 (Enterprise Value 4.91b / Book Value Of Equity 1.17b)
Interest Expense / Debt = 2.63% (Interest Expense 57.8m / Debt 2.20b)
Taxrate = 26.08% (84.5m / 324.0m)
NOPAT = 509.8m (EBIT 689.7m * (1 - 26.08%))
Current Ratio = 1.00 (Total Current Assets 1.43b / Total Current Liabilities 1.42b)
Debt / Equity = 2.58 (Debt 2.20b / last Quarter total Stockholder Equity 850.3m)
Debt / EBITDA = 1.83 (Net Debt 1.78b / EBITDA 1.20b)
Debt / FCF = 5.84 (Debt 2.20b / FCF TTM 375.9m)
Total Stockholder Equity = 904.4m (last 4 quarters mean)
RoA = 10.26% (Net Income 462.5m, Total Assets 4.51b )
RoE = 51.14% (Net Income TTM 462.5m / Total Stockholder Equity 904.4m)
RoCE = 24.81% (Ebit 689.7m / (Equity 904.4m + L.T.Debt 1.88b))
RoIC = 17.47% (NOPAT 509.8m / Invested Capital 2.92b)
WACC = 5.95% (E(2.79b)/V(4.99b) * Re(9.10%)) + (D(2.20b)/V(4.99b) * Rd(2.63%) * (1-Tc(0.26)))
Shares Correlation 3-Years: -27.27 | Cagr: -0.04%
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 78.08% ; FCFE base≈448.0m ; Y1≈552.7m ; Y5≈943.0m
Fair Price DCF = 112.0 (DCF Value 13.19b / Shares Outstanding 117.8m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 69.93 | Revenue CAGR: 13.90%
Rev Growth-of-Growth: -44.25
EPS Correlation: -11.19 | EPS CAGR: 0.0%
EPS Growth-of-Growth: -45.37